DCF — INDIANA UNIVERSITY HEALTH
Enterprise Value: $-3.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.2B
Enterprise Value
$-1.1B
PV of Cash Flows
$-2.1B
PV of Terminal Value
$-3.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $3.7B | $-165.8M | -5.0% | $-321.8M | $-292.5M |
| Year 2 | $3.8B | $-132.8M | -4.0% | $-293.5M | $-242.6M |
| Year 3 | $3.9B | $-97.7M | -3.0% | $-263.2M | $-197.7M |
| Year 4 | $4.0B | $-80.5M | -2.0% | $-251.0M | $-171.4M |
| Year 5 | $4.1B | $-72.6M | -2.0% | $-248.1M | $-154.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$3.6B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000004192969
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5